SEOM clinical guideline on hereditary colorectal cancer (2019)

Guillen-Ponce, C.; Lastra, E.; Lorenzo Lorenzo, Isabel; Gomez, T. M.; Chamorro, R. M.; Sanchez-Heras, A. B.; Serrano, R.; Rodriguez, M. C. S.; Soto, J. L.; Robles, L.
Thumbnail
Statistics
Statistics
Identifiers
Identifiers
URI: http://hdl.handle.net/20.500.11940/16778
PMID: 31981079
ISSN: 1699-048X
Full record
Services
Services
RISMendeleyLinksolver
Files view or download
Files view or download
Date issued
2020
Journal title
Clinical & Translational Oncology
Type of content
Journal Article
DeCS
ensayos clínicos como asunto | proteínas de neoplasias | oncología médica | humanos | guías de práctica clínica como asunto | neoplasias colorrectales
MeSH
Clinical Trials as Topic | Humans | Neoplasm Proteins | Medical Oncology | Practice Guidelines as Topic | Colorectal Neoplasms
Abstract
In the last 2 decades, clinical genetics on hereditary colorectal syndromes has shifted from just a molecular characterization of the different syndromes to the estimation of the individual risk of cancer and appropriate risk reduction strategies. In the last years, new specific therapies for some subgroups of patients have emerged as very effective alternatives. At the same time, germline multigene panel testing by next-generation sequencing (NGS) technology has become the new gold standard for molecular genetics.
Atribución 4.0 Internacional
Except where otherwise noted, this item's license is described as Atribución 4.0 Internacional